Form D · Pharmaceuticals

LIPAC Oncology LLC

Pomona, CA · CIK 0001799023

Offering snapshot reported Jul 7, 2020 · SEC filing

Reported sold
$373K
Offering amount: $5M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 9, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$186K$373KFeb 21, 2020: $372,500.00Feb 21, 2020Jul 7, 2020: $372,500.00Jul 7, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 7, 2020Amendment$372,500$0vs Feb 21, 20206SEC filing
Feb 21, 2020Initial$372,500No comparison6SEC filing

Offering details

Securities
Equity, Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-361159

Source: Form D, filed Jul 7, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thirucote Ramachandran Director, Executive
Willem A Robberts Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3670 West Temple Avenue Suite 270
Pomona, CA, 91768